Role of botulinum toxin A in improving facial erythema and skin quality

被引：12

作者：

Hanna, Edith ^{[1
,2
]}

Xing, Lin ^{[1
]}

Taylor, Jennifer H. ^{[1
]}

Bertucci, Vince ^{[1
]}

机构：

[1] Univ Toronto, Temerty Fac Med, Div Dermatol, Toronto, ON, Canada

[2] 1093 Rue Reynald, Laval, PQ, Canada

来源：

ARCHIVES OF DERMATOLOGICAL RESEARCH | 2022年 / 314卷 / 08期

关键词：

General dermatology; Medical dermatology; Cosmetic dermatology; Botulinumtoxin A; Neuromodulators; Injectables; Fillers; Facial erythema; Rosacea; Skin quality; Fine lines; Rhytids; Wrinkles; Facial rejuvenation; Sebum production; Pore size; ROSACEA; INJECTION; EFFICACY; SAFETY;

D O I：

10.1007/s00403-021-02277-0

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Botulinum toxin A (BTX-A) injections have become the most popular noninvasive cosmetic procedures performed worldwide. With growing interest, investigators continue to uncover an expanding array of aesthetic indications for BTX-A. Botulinum toxin A has been used off-label in the management of masseter hypertrophy for facial slimming, platysmal bands, nasal 'bunny' lines, perioral rhytides, gummy smile and scars, to name a few. Interestingly, the injection of multiple microdroplets of dilute BTX-A into the dermis, sometimes referred to as 'microbotox', has been investigated as a tool for facial rejuvenation. A handful of prospective studies and case series have demonstrated the benefit of BTX-A in the treatment of facial erythema and improving skin texture. The aim of this review is to summarize and appraise currently available data on the role of BTX-A in treating facial erythema and skin quality, with a special focus on potential pathophysiologic mechanisms.

引用

页码：729 / 738

页数：10